The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bellón, T.
Right arrow Articles by López-Botet, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bellón, T.
Right arrow Articles by López-Botet, M.
The Journal of Immunology, 2002, 168: 3351-3359.
Copyright © 2002 by The American Association of Immunologists

Mutational Analysis of Immunoreceptor Tyrosine-Based Inhibition Motifs of the Ig-Like Transcript 2 (CD85j) Leukocyte Receptor1

Teresa Bellón2,*, Friederike Kitzig{dagger}, Joan Sayós{dagger} and Miguel López-Botet3,{dagger}

* Hospital de la Princesa, Madrid, Spain; and {dagger} Departament de Ciències Experimentals i de la Salut (Inmunología), Universitat Pompeu Fabra, Barcelona, Spain

The inhibitory receptor Ig-like transcript (ILT)2 (leukocyte Ig-like receptor or CD85j) is a type I transmembrane protein expressed by different leukocyte lineages. The extracellular region of ILT2 binds HLA class I molecules, and its cytoplasmic domain displays four immunoreceptor tyrosine-based inhibition motifs. Upon tyrosine phosphorylation ILT2 recruits the Src homology 2 domain-containing protein tyrosine phosphatase 1 (SHP-1) that is involved in negative signaling. To address the structural basis of ILT2-mediated inhibitory signaling, deletion and single tyrosine mutants were generated and transfected in the COS-7 and rat basophilic leukemia cell lines; their abilities to bind SHP-1 and to inhibit Fc{epsilon}R-induced serotonin release in rat basophilic leukemia cells were studied. Both biochemical and functional analyses revealed tyrosines 644 (SIYATL) and 614 (VTYAQL) as the SHP-1 docking sites required for ILT2 inhibitory function. Substitution of tyrosine 562 (VTYAEV) did not alter receptor function. By contrast, mutation of tyrosine 533 (NLYAAV) interfered with ILT2 tyrosine phosphorylation and the subsequent SHP-1 recruitment, thus supporting a regulatory role for this motif.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Li, B. L. Houser, M. L. Nicotra, and J. L. Strominger
HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells
PNAS, April 7, 2009; 106(14): 5767 - 5772.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Maffei, F. Ghiotto, M. Occhino, M. Bono, A. De Santanna, L. Battini, G. L. Gusella, F. Fais, S. Bruno, and E. Ciccone
Human Cytomegalovirus Regulates Surface Expression of the Viral Protein UL18 by Means of Two Motifs Present in the Cytoplasmic Tail
J. Immunol., January 15, 2008; 180(2): 969 - 979.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. S. Wagner, L. Walther-Jallow, E. Buentke, H.-G. Ljunggren, A. Achour, and B. J. Chambers
Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells
J. Leukoc. Biol., January 1, 2008; 83(1): 56 - 63.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Alvarez-Errico, J. Sayos, and M. Lopez-Botet
The IREM-1 (CD300f) Inhibitory Receptor Associates with the p85{alpha} Subunit of Phosphoinositide 3-Kinase
J. Immunol., January 15, 2007; 178(2): 808 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Imhof, A.-S. Wavreille, A. May, M. Zacharias, S. Tridandapani, and D. Pei
Sequence Specificity of SHP-1 and SHP-2 Src Homology 2 Domains: CRITICAL ROLES OF RESIDUES BEYOND THE pY+3 POSITION
J. Biol. Chem., July 21, 2006; 281(29): 20271 - 20282.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. Kirwan and D. N. Burshtyn
Killer Cell Ig-Like Receptor-Dependent Signaling by Ig-Like Transcript 2 (ILT2/CD85j/LILRB1/LIR-1)
J. Immunol., October 15, 2005; 175(8): 5006 - 5015.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Kuroki, N. Tsuchiya, M. Shiroishi, L. Rasubala, Y. Yamashita, K. Matsuta, T. Fukazawa, M. Kusaoi, Y. Murakami, M. Takiguchi, et al.
Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis
Hum. Mol. Genet., August 15, 2005; 14(16): 2469 - 2480.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Aguilar, D. Alvarez-Errico, A. C. Garcia-Montero, A. Orfao, J. Sayos, and M. Lopez-Botet
Molecular Characterization of a Novel Immune Receptor Restricted to the Monocytic Lineage
J. Immunol., December 1, 2004; 173(11): 6703 - 6711.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Gonen-Gross, H. Achdout, R. Gazit, J. Hanna, S.'a. Mizrahi, G. Markel, D. Goldman-Wohl, S. Yagel, V. Horejsi, O. Levy, et al.
Complexes of HLA-G Protein on the Cell Surface Are Important for Leukocyte Ig-Like Receptor-1 Function
J. Immunol., August 1, 2003; 171(3): 1343 - 1351.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Faure, D. F. Barber, S. M. Takahashi, T. Jin, and E. O. Long
Spontaneous Clustering and Tyrosine Phosphorylation of NK Cell Inhibitory Receptor Induced by Ligand Binding
J. Immunol., June 15, 2003; 170(12): 6107 - 6114.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.